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ABSTRACT: A high-throughput label-free resonant waveguide
grating biosensor, the Epic BenchTop, was utilized to in situ
monitor the adhesion process of cancer cells on Arg-Gly-Asp
tripeptide displaying biomimetic polymer surfaces. Using highly
adherent human cervical adenocarcinoma (HeLa) cells as a
model system, cell adhesion kinetic data with outstanding
temporal resolution were obtained. We found that pre-exposing
the cells to various concentrations of the main extract of green
tea, the (−)-epigallocatechin gallate (EGCG), largely aﬀected
the temporal evolution of the adhesion process. For unexposed
and low dosed cells, sigmoid shaped spreading kinetics was
recorded. Higher dose of EGCG resulted in a complete absence
of the sigmoidal character, and displayed adsorption-like
kinetics. By using the ﬁrst derivatives of the kinetic curves, a
simple model was developed to quantify the sigmoidal character and the transition from sigmoidal to adsorption-like kinetics.
The calculations showed that the transition happened at EGCG concentration of around 60 μg/mL. Using the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide end-point assay, we concluded that EGCG is cytostatic but not cytotoxic.
The eﬀect of EGCG was also characterized by ﬂow cytometry. We concluded that, using the introduced label-free methodology,
the shape of the cell adhesion kinetic curves can be used to quantify in vitro cell viability in a fast, cost-eﬀective, and highly
sensitive manner.
■ INTRODUCTION
Natural compounds are becoming more and more popular in
biomedicine, especially in cancer treatment and to develop
novel antimicrobial agents.1−4 Tea catechins, especially
(−)-epigallocatechin gallate (EGCG), have been shown to
have various health beneﬁts, for example, anti-metastasis,
anticancer, anti-inﬂammatory, and antioxidant properties, and
can prevent cardiovascular disease as well.5−8 EGCG is one of
the most studied active substances, and many studies observed
its eﬀects on several cancer and normal cell types, and in animal
models.4 This compound has signiﬁcant impact on cell
adhesion and movement, apoptosis, and proliferation, generally
by altering gene expression.4,5,9−11 Tea polyphenols are well
known for their antioxidant activities, too.5,12 Among them,
EGCG is the most eﬀective compound interacting with reactive
oxygen species.13 EGCG and other catechins are unstable at
high temperature and under alkaline and neutral conditions;
EGCG oxidizes and dimerizes easily5,12,14at pH above 7.5,12,14
In an aqueous solution, it changes from noncolored at around
natural pH to yellow at higher pH; the absorption in the UV
range becomes more pronounced.4,5,15
Determination of cell viability is a critical step in screening
the eﬃcacy of compounds, when evaluating the response to
cytotoxic moiety. Flow cytometry is a sensitive and mainstream
method to determine compound-induced cytotoxic eﬀects and
cell death. The main advantage of the method allows the
analysis on a per-cell basis using ﬂuorescent dyes to enter viable
or dead cells. Propidium-iodide (PI) is a polar, ﬂuorescent
Received: December 1, 2017
Accepted: March 5, 2018
Published: April 5, 2018
Article
Cite This: ACS Omega 2018, 3, 3882−3891
© 2018 American Chemical Society 3882 DOI: 10.1021/acsomega.7b01902
ACS Omega 2018, 3, 3882−3891
This is an open access article published under a Creative Commons Attribution (CC-BY)
License, which permits unrestricted use, distribution and reproduction in any medium,
provided the author and source are cited.
compound and can only enter cells that lack membrane
integrity. After PI staining, nonviable cells show a bright red
ﬂuorescence, whereas viable cells remain nonﬂuorescent.16
Using the plate-based 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide (MTT) method, the membrane
permeability and mitochondrial activity of the cells were
determined in metabolically active cells.17
However, most of the label-based assays have serious
disadvantages, for example, labeling techniques use ﬂuorescent
markers that may aﬀect normal cell behavior and the imaging
time is often limited by the low signal and the bleaching of the
marker.5
Detection of cellular adhesion is of signiﬁcant diagnostic and
basic research utility. Changes in cell adhesion can be a sign for
various illnesses; for example, the variety of integrins, a major
group of cell adhesion receptors that bind to the extracellular
matrix, changes during tumor transformation.5 Measurement of
the eﬀect of bioactive substances on the adhesion of tumor cells
Figure 1. Schematic illustration of the working principle of the Epic BT biosensor. An optical biosensor found in each well is illuminated by a
broadband light source. The biosensor contains a grating coupled planar optical waveguide and its surface can be coated with a protein or polymer of
interest. Light coupled into the waveguide creates a resonant mode and a corresponding evanescent ﬁeld penetrating to a depth of 150 nm above the
sensor surface. Any refractive index change inside the evanescent ﬁeld shifts the resonant wavelength of light reﬂected back from the biosensor. The
biosensor signal is the wavelength shift of the reﬂected light. (A) If there is no change in the evanescent ﬁeld, there is no signal. (B) The cell attaches
but does not adhere onto the biosensor surface. This phenomenon represents an adsorption kinetic curve, which indicates a nonliving, “dead”
process. Note, it also occurs when proteins adsorb onto the surface. (C) The cells adhere onto the biosensor surface. This phenomenon represents a
sigmoidal kinetic curve, which indicates a “living” process. (D) Schematic graph of the diﬀerence (Δλ) between the resonant peak wavelengths of the
reﬂected lights. The equipment plots the Δλ data in time during the experiment (see C and B).
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can be an eﬀective tool in the design of antineoplastic
pharmaceuticals.5 A wide range of previously existing and
well-documented, conventional label-based experimental meth-
ods are available to assess cellular processes such as in vitro cell
viability and adhesion.5,18−25
Label-free biosensors, not requiring the usage of dyes, have
the ability to become a routine tool for measuring cell adhesion,
spreading, proliferation, signalization, and cytotoxicity as well.5
These techniques are especially promising when the real-time
kinetics of interactions have to be investigated.
In the measurements of label-free techniques, biomimetic
surfaces are usually applied as coatings to create circumstances
that resemble the real biological conditions. The biomimetic
surfaces mimic the materials that occur in vivo, but these
artiﬁcial substrates are simpler to hand, they need less
preparations, and the created coatings are more reproducible.
Poly(L-lysine)-graf t-poly(ethylene glycol) (PLL-g-PEG) is a
biomimetic polycationic copolymer with poly(ethylene glycol)
(PEG) chains covalently grafted onto a positively charged PLL
backbone. It spontaneously adsorbs from the aqueous solution
via electrostatic interactions onto negatively charged surfaces
such as tissue culture polystyrene, TiO2, Nb2O5, and SiO2.
5,26,27
However, several studies have shown that it can also adsorb
onto nonpolar, hydrophobic poly(dimethylsiloxane) (PDMS)
surfaces from the aqueous solutions. The PEG side chains
stretch into the bulk aqueous solution to generate a brushlike
Figure 2. Summarized schematic illustration of the label-free method employing the Epic BT biosensor. Cells were pre-exposed to various
concentrations of EGCG and then transferred to the biosensor wells to record their adhesion and spreading on the RGD displaying polymer
surfaces. As the most striking observation, cell spreading with low concentration of EGCG or without EGCG shows sigmoidal-like kinetic curves
(active, living process), whereas treatments with high concentration of EGCG result in adsorption-like kinetic curves (dead process).
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conformation due to its high aﬃnity for water. Recent studies
have shown that a PLL-g-PEG layer on metal oxide surfaces
displays resistance to a nonspeciﬁc adsorption of proteins and
cell adhesion.5,27,28
The copolymer and its cell adhesive, functionalized counter-
part with Arg-Gly-Asp (RGD) motif, PLL-g-PEG-RGD, can be
mixed to vary the cell adhesion ligand density and to promote
cell adhesion and spreading on the coated surfaces.5 Here, we
use the mixture of PLL-g-PEG and PLL-g-PEG-RGD to create
highly cell adhesive surfaces in a reproducible manner.5,29,30
In the present work, we investigate the adhesion kinetics of
EGCG pre-exposed cells on PLL-g-PEG-RGD as biomimetic
surfaces using the Epic BenchTop (BT) resonant waveguide
grating (RWG) biosensor. The Epic BT employs resonant
waveguide gratings arranged in a 96- or 384-well array format.
In each well, the resonant wavelength of the waveguide is
monitored, which is sensitive to refractive index variations
above the sensing surface. This surface-sensitive high-
throughput label-free technique was previously demonstrated
to monitor cell signaling and adhesion.5,30−35 Thanks to its
excellent temporal resolution, the cellular adhesion can be
recorded with unprecedented data quality.30 This feature is
exploited in the present work by investigating the shapes of the
cell adhesion kinetic curves in detail. A simple model is created
to quantify the shape of the kinetic curves. The results of the
label-free investigations are compared with classical MTT assay
and ﬂow cytometry employing PI staining. Our work
demonstrates a novel way to measure cell viability in a fast,
label-free, and highly sensitive manner.
■ RESULTS AND DISCUSSION
In vitro eﬀect of EGCG on cellular viability was accessed by
three diﬀerent methods using HeLa cells: (i) to analyze real-
time cell adhesion kinetics, (ii) to determine metabolic activity
using colorimetric MTT assay, and (iii) to quantify dead or
dying cells by cytoﬂuorometry with PI staining.
The plate-based EPIC system is suitable for observing
adhesive parameters in real time as physiologically relevant and
quantitative data related to the cellular ﬁtness and viability. The
optical core of the sensing procedure is schematically illustrated
in Figure 1. Using classic end-point tetrazolium reduction, the
cytostatic or cytotoxic activity can be determined through
enzymatic activity as a marker of viable cells generating a signal
that is proportional to the number of viable cells.
Adhesion Kinetics of EGCG Pre-Exposed Cells
Recorded by the Optical Biosensor. The schematic
illustration of the employed methodology is summarized in
Figure 2. One can observe an interesting phenomenon on the
kinetic curves measured by Epic BT.
If the cells can well adhere and spread, sigmoidal-like curves
can be monitored as a characteristic pattern of living cells
(living process). In contrast, at higher concentration,
adsorption-like curves imply that the observed change is due
to dying or dead cells (dead process). Note, the adsorption-like
curves are typically observed when discrete objects are
adsorbing on a solid surface. In this case, the main driving
force is the unoccupied surface area; therefore, the adsorption is
fastest at the very beginning, when the free surface area is
maximal. In contrast, the sigmoidal kinetics require an active,
self-catalytic, and self-controlled mechanism, a unique charac-
teristics of the living cells.
In these measurements, we both monitored the sigmoidal-
and adsorption-like kinetic curves, depending on the
concentration of the EGCG. At values lower than the added
40 μg/mL of EGCG, we received spreading curves (active,
living process), and above this value, adsorption curves (dead
process) (Figure 3). (Supposedly, due to the EGCG, the
cellsinstead of active adhesionmay even secrete some cell-
speciﬁc compounds at higher extract concentrations.) This
border concentration is approximately 40−50 μg/mL, above
which the EGCG has harmful eﬀects on the cancer cells.
Following the EGCG preincubation, our observation was
that the size of the cells shrunk and their shape, spreading, and
adhesive properties also changed. The microscopy images
(Figure 4) clearly show that at low EGCG concentrations (0−
40 μg/mL), the cells could well adhere and spread; after the 2 h
period, the cells almost formed a homogeneous layer on the
RGD displaying a biosensor surface. However, at higher EGCG
concentrations of 40−50 μg/mL, the shape of the cells
changed; they are not as spread as the other cells with lower
concentrations or without green tea extract. At higher
quantities, the cells remained rounded. The observation of
the same phenomenon can be followed on the kinetic curves as
mentioned earlier.
In Vitro Cytotoxic and Cytostatic Activity of the
Compound EGCG on HeLa Cell Culture (MTT assay).
Tetrazolium salts are widely used for in vitro assessment of
metabolic activity of cells. 3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) reduction is one of the
most frequently used methods for measuring cytotoxicity and
cell proliferation.36 HeLa cells were treated with EGCG at
0.064−500 μg/mL concentration range and the viability of the
cells was determined by using the MTT assay.
The 50% inhibitory concentration (IC50) values were
determined from the dose−response curves. We found that
EGCG exhibited a modest, but not negligible cytotoxic eﬀect
on HeLa cells (IC50 > 500 μg/mL). From the dose−response
curves, it can be observed that the results obtained with the
Epic BT measurements are reconcilable: the transition
concentration is probably 20−30 μg/mL in the MTT cell
cytotoxicity assay as well. The cytostasis assay (at 0.064−1000
Figure 3. Kinetic cell adhesion curves recorded by Epic BT. The
plotted lines represent the averaged values of the three parallel
experiments. For obtaining these data, the cells were preincubated with
solutions having diﬀerent EGCG concentrations. After, these treated
cells were pipetted into the biosensor wells and cell adhesion was
monitored for 2 h. It is clearly seen that increasing the EGCG
concentration decreases the sigmoidal character of the kinetic curves.
For the highest EGCG concentrations, the sigmoidal character is
completely missing and adsorption-like curves are recorded.
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μg/mL concentration range) shows higher inhibitory concen-
trations.
Evaluation of Viability Proﬁles of EGCG-Treated HeLa
Cells by Flow Cytometry. The cells were exposed to EGCG
for 1.5 h. Following the exposure and removal of EGCG by
washing and trypsinization of the cells, they were transferred to
the FACS tubes and stained with PI. As HeLa is an adherent
culture, when preparing the samples for assay, the cells is
carefully harvested to avoid the loss or damage of a certain
subpopulations, and the cells are thoroughly processed to
single-cell suspension before PI staining. The data shown are
typical of those obtained from repeated experiments. The
spontaneous cell death due to sample preparation was
determined for untreated control cells (5−10% of death). For
maximum lysis (100% of death), the cells were incubated at 37
°C with 20 μL of saponin at 0.3 mg/mL (data not shown). A
threshold was set on the forward scatter to exclude cell debris
or any artifacts. The gates that were obtained with FACSDiva
software and used for data acquisition. The gated dead cells
were displayed on a histogram of log-scale red ﬂuorescence of
PI to enable the diﬀerentiation between dead and live HeLa
cells. The cell death was expressed as the percentage of PI
positive cells.
Quantiﬁcation of the Shape of the Label-Free Kinetic
Curves: Comparison with Classical Cell Viability Assays.
We analyzed the kinetic curves of the Epic BT in more detail by
using the following ideas. First, the kinetic data were
diﬀerentiated (ﬁrst derivative) and the following parameter
was calculated.
λ λΔ = Δ − Δ
=t t
d
d
d
d tmax 0 (1)
λΔ
t
d
d max
is the ﬁrst derivative maximal value, λΔ
=t t
d
d 0
is the ﬁrst
derivative at the t = 0 timepoint (see Figures 6 and 7 for more
details). Note, in the actual calculations, the ﬁrst derivative
recorded at 2.5 min was used instead of the ﬁrst derivative at t =
0 due to practical reasons.
The parameter Δ characterizes the shape of the kinetic
curves in a straightforward manner. Simply, if Δ > 0 pm/min,
the recorded curve has a sigmoidal character. For all
adsorption-like curves (having the maximum of the ﬁrst
derivative at t = 0), the parameter Δ is zero. Therefore, these
two types of behaviors can be well distinguished.
The schematic illustration of the method is seen in Figure 5
with all of the relevant parameters highlighted. The time
dependency of the ﬁrst derivatives for the actual biosensor
measurements are plotted in Figure 6.
Figure 4. Microscopic images of the cells after the measurement in the Epic BT microplate wells. (A) Cells without EGCG treatment could spread
onto the surface and form adhesive contacts. (B) Cells treated with 250 μg/mL EGCG (highest concentration) remained rounded and spreading was
inhibited. Scale bar: 100 μm. The diﬀerences between the cells treated by the lowest EGCG concentrations cannot be detected by phase contrast
microscopy (images not shown). Note, in contrast, the label-free kinetic curves well demonstrate the diﬀerences even at low EGCG concentrations
(see Figure 3 for more details).
Figure 5. Schematic illustration of the calculation method to reveal the
transition EGCG concentration from the Epic BT data from
sigmoidal- to adsorption-like curves. (A) Typical sigmoidal- and
adsorption-like kinetic curves. (B) The ﬁrst derivative of the curves
plotted in (A) with the parameters appearing in the equation of Δ
highlighted. In case of adsorption-like curves, the parameter Δ is 0
because the ﬁrst derivative at t = 0 timepoint is equal to the ﬁrst
derivative’s maximum value.
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Next, the Δ values for various EGCG concentrations were
plotted with the concentration data at the x-axis (logarithmic
scale), and the data points were ﬁtted with a linear curve
(Figure 7A). The Δ values are 0 pm/min at concentrations
higher than 40 μg/mL and >0 at lower concentrations. The
exact transition concentration is 60 ± 40 μg/mL, calculated by
linear extrapolation (Figure 7A). The error of the calculation is
estimated from the standard errors of the linear ﬁt. To compare
the label-free data with the ﬁndings of the labeling methods, we
plotted the MTT cytostasis (Figure 7B), cytotoxicity (Figure
7C), and ﬂow cytometry results (Figure 7D).
The calculated transition concentration is compatible with
the MTT assay because this is the point where the ﬁtted dose−
response curve (cytostatic activity) starts to increase as well.
From the results shown in Figure 7, the novel method based on
Epic BT seems to be much more sensitive because it shows
evident dose dependence even under eﬀective, transition
concentration as well, whereas the other two MTT curves do
not show a diﬀerence. Therefore, there is a dose-dependent
noncytotoxic eﬀect as well, which can be clearly monitored and
highlighted by Epic BT. Therefore, the above protocol might
serve as an alternative way to quantitatively characterize cell
viability in a completely label-free and highly sensitive manner.
In general, the Epic BT assay was more sensitive than the
ﬂow cytometric or MTT assay. The MTT assay gave results
approximately comparable to those from the ﬂow cytometric
assay. In comparing the ﬂow cytometric with the MTT assay,
we ﬁnd higher standard deviations with the ﬂow cytometric
assay (standard deviation less than 10−15% of mean versus 6−
8% for the MTT assay).
Moreover, Epic BT is a high-throughput and fast method.
Only 1 h would have been enough to receive the maximum
values of the derivative curves (see Figure 6). These features
make this measurement technique highly cost-eﬀective too,
when compared with standard biosensing equipment having a
single measurement channel. Signiﬁcant amount of time can be
saved by performing hundreds of experiments in a single run.
Moreover, the status of the cells and the condition of the
reagents are always the same in these parallel performed
experiments. It should be also emphasized that the results
obtained by the biosensor are not aﬀected by any molecules
typically used for labeling and possibly even interacting with the
investigated compounds.
Figure 6. First derivatives of the kinetic curves recorded by Epic BT
(and plotted in Figure 4). Data corresponding to HeLa cells treated by
EGCG from 0 to 250 μg/mL concentrations and a buﬀer control is
shown. It is clearly seen that the character of the kinetic curves
drastically changes as the EGCG concentration is increased.
Figure 7. Calculated dose−response curves and the transition
concentration compared with the results of the MTT and
cytoﬂuorimetric assays. (A) Plotted and ﬁtted Δ values. On the left,
Δ > 0 pm/min, indicating an active cell spreading process. On the
right, at higher EGCG concentrations, Δ values are 0 pm/min,
showing an adsorption-like process. The transition concentration
between these two types of behaviors is 60 ± 40 μg/mL, calculated by
linear extrapolation. (B) Result of the in vitro cytostatic activity assay.
It shows higher inhibitory concentrations than cytotoxicity test. (C)
Result of the in vitro cytotoxicity assay (MTT assay). EGCG exhibited
a modest, but not negligible cytotoxic eﬀect on HeLa cells (IC50 > 500
μg/mL). (D) Result of the in vitro ﬂow cytometry assay. Cell death
rate was expressed as the percentage of PI positive cells.
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■ CONCLUSIONS
Cell-based assays are widely used to determine if a compound
has a cytostatic activity or a direct cytotoxic eﬀect leading to cell
death. To access cellular viability plays an important role in the
functional characterization of a molecule. There are wide
variety of cell viability methods that provide accurate picture of
cytostatic and cytotoxic activity, such as colometric assays and
cytoﬂuorimetric analysis of individual cells. Previous studies
have shown that EGCG can inhibit cell adhesion,5,23,24,37 and
this extract has an obstructive eﬀect not just on cancer cell
adhesion but also on cell movement and can induce apoptosis
too,9,23,24,37−39 whereas EGCG has an inﬂuence on cell viability
as well. The classic colorimetric end-point method to evince
this eﬀect is the MTT assay; however, both MTT- and 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfo-
phenyl)-2H-tetrazolium (MTS)-based assays underestimate the
antiproliferative eﬀect of EGCG. This phenomenon is probably
due to the increased activity of mitochondrial dehydrogenase in
response to the EGCG treatment, as well as the intrinsic
potential of EGCG to reduce MTT and MTS and increase the
formation of formazan.17 Thus, a careful evaluation of the
applied method is essential for the in vitro assessment of cell
viability and proliferation17 after EGCG treatment.
To monitor compound-induced, real-time dose response,
label-free technologies were demonstrated to be robust, but
sensitive tools with high statistical signiﬁcance and reduced
artifacts.32,40,41
In this study, the Epic BTa novel high-throughput label-
free RWG biosensorwas applied to study the eﬀect of EGCG
on the kinetics of cancer cell adhesion. The recorded real-time
adhesion curves were compared with the data of MTT and ﬂow
cytometric cell viability assays.
On the basis of the kinetic information, we identiﬁed normal
spreading curves, i.e., an active process of living HeLa cells, at
EGCG concentrations lower than 60 μg/mL. Above this
concentration, we observed simple adsorption curves lacking
normal cell spreading, i.e., a cytostatic eﬀect on HeLa cells is
seen. We calculated that 60 ± 40 μg/mL is a transition
concentration between the two types of kinetic curves by
developing a straightforward mathematical methodology. This
concentration value is the starting point of the increasing part
of the ﬁtted cell viability cytostatic curve obtained from the
MTT assays. Our results show that the high-throughput Epic
BT biosensor can be successfully applied in cytotoxicity assays
with a superior sensitivity.
Our technique oﬀers a noninvasive, label-free, cost-eﬀective
platform to characterize cell viability with a high sensitivity and
an accurate correlation with the conventional (classical)
tetrazolium method. Furthermore, this appliance distinguishes
the diﬀerences between the eﬃcacy caused by very low EGCG
concentrations as well, whereas the eﬀects of low concen-
trations were too small to be reliably deﬁned by the
colorimetric or ﬂow cytometry methods. These data points
were represented as scattered ﬂat sections (plateaus) on the
respective graphs. The intensity of the measured signal (eﬀect
of EGCG based on absorbance or intracellular ﬂuorescence
intensity) is not detectable or diﬃcult to quantify; the small
changes produced by low concentrations of EGCG become lost
within the base noise.
Using the label-free method, the observation range was
considerably extended due to the enhanced signal-to-noise
ratios. The data evaluation and the quantiﬁcation of the
diﬀerences are simpler in the case of Epic BT as well. Thus, it
may have an important role in biomedical research, for
example, in early or second stage drug candidate testing due
to its predictive ability. In our opinion, another possible scope
of the introduced methodology is the testing of cytostatic or
cytotoxic compounds on diﬀerent tumor cells even from
patients to ﬁnd drugs that are harmful to the drug-resistant
tumor cells as well. One would be able to measure a lot of
active substances simultaneously in a very short time (in
approximately 1 h); 16 drugs with their 8 concentrations or 8
drugs with their 16 concentrations in the case of a 384-well
plate in triplicates. In this measurement/diagnostic, the spread
cells could be separated from the dead ones in the ﬁrst run, and
then the survived cells could be treated with other active
compounds in the second run.
■ MATERIALS AND METHODS
Synthetic Polymer Solutions. The synthetic copolymers,
poly(L-lysine)-graf t-poly(ethylene glycol) (PLL-g-PEG,
[PLL(20)-g(3.5)-PEG(2)]) (hereafter PP) and its RGD
f un c t i o n a l i z e d c o un t e r p a r t , P LL - g - P EG/PEG -
GGGGYGRGDSP (PLL-g-PEG-RGD [PLL(20)-g(3.5)-PEG-
(2.3)/PEG(3.4)-RGD]) (hereafter PPR), were obtained as
powders from SuSoS AG, Dübendorf, Switzerland. The
materials were stored at −20 °C until use. Each powder was
then dissolved in 10 mM 4-(2-hydroxyethyl)-1-piperazine
ethanesulfonic acid (HEPES, Sigma-Aldrich Chemie GmbH,
Schelldorf, Germany) at pH 7.4 to make stock the solutions
with a concentration of 1.0 mg/mL. The coating solution with
RGD motifs and PLL-g-PEG were prepared by mixing the two
1 mg/mL stock solutions (hereafter PP/PPR).5,30
Preparation of EGCG Solutions. The EGCG powder
(Sigma-Aldrich Chemie GmbH, Schelldorf, Germany) was
solved in 10 mM HEPES at pH 7.4, or in an assay buﬀer
(Hank’s Balanced Salt Solution (HBSS, Sigma-Aldrich Chemie
GmbH, Schelldorf, Germany) containing 20 mM HEPES, pH
7.0, hereafter HBSS−HEPES). The concentration of the
dissolved EGCG solution was 1, 10, 20, 40, 80, 100, 200, and
500 μg/mL, resulted in a ﬁnal concentration of 0.5, 5, 10, 20,
40, 50, 100, and 250 μg/mL, respectively, in the biosensor
wells.
Cell Culture and Cell Adhesion Assay Buﬀer. HeLa cells
(ECACC 93021013 human, cervix, epitheloid, carcinoma) were
routinely cultured in tissue culture polystyrene Petri dishes
(Greiner Bio-One International GmbH, Kremsmünster, Aus-
tria) placed in a humidiﬁed incubator (37 °C, 5% CO2). The
cells were maintained in Dulbecco’s modiﬁed Eagle’s medium
(DMEM), supplemented with 10% fetal bovine serum (FBS,
Biowest SAS, France), 4 mM L-glutamine, 0.25 μg/mL
amphotericin B, 100 U/mL penicillin, and 100 μg/mL
streptomycin solution. On reaching 80% conﬂuence, the cells
were detached every 3−4 days using 0.05% (w/v) trypsin and
0.02% (w/v) ethylenediaminetetraacetic acid (EDTA) solution
and not used beyond passage 20.6,38 The cell adhesion assay
buﬀer was prepared by adding 20 mM HEPES to HBSS and
adjusted to pH 7.0 with a 1 mM NaOH.5,30
Epic Benchtop Resonant Waveguide Grating Bio-
sensor. We used the Epic BenchTop (BT) system (Corning
Incorporated, Corning, NY), a next-generation resonant
waveguide grating (RWG) imager biosensor. It accepts 96- or
384-well Society for Biomolecular Screening standard format
biosensor microplates. The bottom of the microplate is a planar
optical waveguidea thin, high refractive index, transparent
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dielectric layer (waveguide layer, made of the biocompatible
material niobium pentoxide) deposited on a thicker glass
substratum.5,30 At the central position of each well, a 2 × 2
mm2 optical grating is embedded into the optical structure to
enable the interrogation of the TM0 waveguide mode using a
near-infrared electromagnetic radiation. Thus, individually
addressable biosensors are created in each well of the
microplate. All wells of an Epic microplate are simultaneously
interrogated every 3 s by sweeping the illuminating wavelength
through a range of 15 000 pm with 0.25 pm precision (in the
range of 825−840 nm).5,30 Waveguide mode excitation only
happens at a certain wavelength, called the resonant wavelength
(λ). The refractive index variation in an approximately 150 nm
thick layer (in the probing depth of the so-called evanescent
wave) over the biosensor surface shifts the resonant wavelength
to λ′. The refractive index variation can be caused by, for
example, bulk refractive index change, molecular adsorption,
cell spreading, or dynamic mass redistribution inside the cells.
The primary signal output of the Epic BT system is the shift in
the resonant wavelength (Δλ = λ′ − λ) in each well.5,30
EGCG Pretreatment of Cancer Cells and the Biosensor
Measurement. Wells were given 30 μL assay buﬀer to prewet
the sensors and establish a baseline with the RWG imager.
Following the stabilization of the biosensor signal, the
measurement was stopped and the buﬀer was replaced with
30 μL of the coating solution and incubated for 0.5 h while
gently shaking at room temperature.30 The coating solutions
were then removed and the wells were rinsed three times with
30 μL of the assay buﬀer, the polymers adsorbed to the surface
irreversibly. Wells were then dosed with 30 μL assay buﬀer for
the fourth time to establish a new baseline for the subsequent
room temperature cell spreading assay.30 HeLa cells were
trypsinized with 1× prewarmed trypsin−EDTA. Trypsin was
removed before complete detachment of HeLa cells and its
activity arrested by adding culture medium containing 10%
FBS.30 Harvested cells were centrifuged at 380g for 6 min and
the cell pellet was resuspended in assay buﬀer with intensive
pipetting. Cell suspensions and EGCG solutions (in diﬀerent
concentrations) were pipetted in 1:1 ratio into 9 eppendorf
tubes (with a total volume of 340 μL in each tubes), and they
were incubated together for 3 min. Later, we centrifuged them
again for 6 min at 380g. We removed the supernatant from the
cells, and the assay buﬀer was added to the cells. The 20 000
treated cells/well were pipetted into the biosensor wells,
without replacing the plate from the Epic BT. Spreading was
monitored until saturation of the biosensor signals. Averaging
every 5 subsequent data points, the eﬀective sampling rate was
1/15 s−1.3030 At the end of the biosensor measurement, the
microplate was placed under a Zeiss Observer microscope to
visually observe and image the cells with a 20× objective (all
wells were completely ﬁlled up with assay buﬀer and covered
with a microscope slide to improve imaging quality by
eliminating the disturbing meniscus).30 All experiments were
done in triplicates in three diﬀerent wells at room temperature,
and only the averaged data were used for further processing.5,30
MTT Cell Viability Assay. HeLa cells were plated into a 96-
well plate with an initial cell number of 12 500 per well. After
24 h incubation at 37 °C, the cells were treated with the
compound EGCG in 200 μL serum-free medium or in 200 μL
HBSS−HEPES buﬀer. The cells were incubated with the
compounds at 0.064 to 500 or 1000 μg/mL concentration
range for 2 h. The control cells were treated with serum-free
medium only or with HBSS−HEPES buﬀer at 37 °C for 2 h.
After washing the cells three times with serum-free medium or
HBSS−HEPES buﬀer, the viability was determined by MTT.25
A 45 μL MTT solution (2 mg/mL) was added to each well.42
After 3 h of incubation, the cells were centrifuged for 5 min
(380g) and supernatant was removed. The obtained formazan
crystals were dissolved in dimethyl sulfoxide and optical density
(OD) of the samples was measured at λ = 540 and 620 nm
using enzyme-linked immunosorbent reader (iEMS Reader,
Labsystems, Finland). The OD620 values were substracted from
the OD540 values. In the case of cytostatic eﬀect determination,
the cells were cultivated for further 72 h in DMEM medium at
37 °C after the washing steps. After 72 h, the viability was
determined by the MTT.
The percent of cytotoxicity and cytostatic eﬀect was
calculated using the following equation
= − ×
cytotoxicity/cytostasis %
[1 (OD /OD )] 100treated control (2)
where ODtreated and ODcontrol correspond to the optical
densities of the treated and the control cells, respectively. In
each case, two independent experiments were carried out with
four parallel measurements. The 50% inhibitory concentration
(IC50) values were determined from the dose−response curves,
which were deﬁned using a MicrocalTM Origin1 (version 8.6)
software.
Flow Cytometry. Before cell plating, the plates were coated
with PP/PPR 1:1 v/v (total volume of 10 μL, shaking for 3
min, after washing with 200 μL of HBSS buﬀer three times).
HeLa cells (1 × 105 cells per well) were plated in 24-well
plates. The cells were stimulated with the medium alone, or
with EGCG (0.0039−1 mg/mL) solutions for 1.5 h. After
treatment, the supernatants were removed and the cells were
washed with serum-free DMEM media and then the adherent
cells were treated with 100 μL trypsin solution (Sigma, 2.5 g/L
porcine trypsin solution in 0.9% sodium chloride), trypsin
digestion was blocked using HPMI buﬀer (20 mM HEPES, 132
mM NaCl, 3.5 mM KCl, 0.5 mM MgCl2, 5 mM glucose, 1 mM
CaCl2 [pH 7.4])
43 supplemented with 10% (wt/vol) fetal
bovine serum (FBS, Sigma) and the cells were collected by
centrifugation at 300g for 5 min and then washed twice with the
serum-free HPMI buﬀer. The pellets were resuspended in the
HPMI buﬀer.
The cell viability was assessed using 10 μg/mL PI solution
(for the gating strategy, ﬂuorescence parameters were gated
using unstained and the PI-stained untreated control cells, and
10 000 cells were counted for each treatment). PI was excited at
488 nm, using a BD LSR II ﬂow cytometer (BD Biosciences,
San Jose, CA) Coherent Sapphire, 22 mW laser. After staining,
the intracellular ﬂuorescence intensity of the cells was measured
on channel PE LP550 and the data were analyzed with a
FACSDiva 5.0 software. All measurements were performed in
triplicates.
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Epigallocatechin Gallate Reduces Human Monocyte Mobility and
Adhesion in Vitro. Br. J. Pharmacol. 2009, 158, 1705−1712.
(38) Tudoran, O.; Soritau, O.; Balacescu, O.; Balacescu, L.; Braicu,
C.; Rus, M.; Gherman, C.; Virag, P.; Irimie, F.; Berindan-Neagoe, I.
Early Transcriptional Pattern of Angiogenesis Induced by EGCG
Treatment in Cervical Tumour Cells. J. Cell. Mol. Med. 2012, 16, 520−
530.
(39) Hayakawa, S.; Saeki, K.; Sazuka, M.; Suzuki, Y.; Shoji, Y.; Ohta,
T.; Kaji, K.; Yuo, A.; Isemura, M. Apoptosis Induction by
Epigallocatechin Gallate Involves Its Binding to Fas. Biochem. Biophys.
Res. Commun. 2001, 285, 1102−1106.
(40) Xi, B.; Yu, N.; Wang, X.; Xu, X.; Abassi, Y. A. The Application of
Cell-Based Label-Free Technology in Drug Discovery. Biotechnol. J.
2008, 3, 484−495.
(41) Pamenter, M. E.; Haddad, G. G. High-Throughput Cell Death
Assays. Methods Mol. Biol. 2015, 1254, 153−163.
(42) Denizot, F.; Lang, R. Rapid Colorimetric Assay for Cell Growth
and Survival. Modifications to the Tetrazolium Dye Procedure Giving
Improved Sensitivity and Reliability. J. Immunol. Methods 1986, 89,
271−277.
(43) Kapuslo, A.; Grinsteinm, S.; Kandasamyll, R.; Orlowskill, J.
Functional Characterization of Three Isoforms of the Na +/H +
Exchanger Stably Expressed in Chinese Hamster Ovary Cells. J. Biol.
Chem. 1994, 269, 23544−23552.
ACS Omega Article
DOI: 10.1021/acsomega.7b01902
ACS Omega 2018, 3, 3882−3891
3891
